News

Dispensing practices told how to avoid earnings drop

20-Nov-07

Dispensing GPs have been urged to maximise dispensing and minimise expenditure in the wake of a forecast earnings drop.

With reports of GP earnings for 2006/7 due to fall by 7 percent, and a further 7 percent in the year 2007/8, Dr Richard West, chairman of the Dispensing Doctors’ Association, added to the gloom by confirming that dispensing GPs’ earnings were also likely to drop considerably.

‘In the last nine to 12 months, PCTs have been pushing for a change from branded drugs to generics. Category M (the pricing reimbursement structure for 90 percent of generic drugs) has pushed prices down.

‘The dispensing envelope did not increase in 2006/7, and staff still want a pay increase,’ he added.

Asked how practices should minimise earnings drops in 2007/8, Dr West advised practices to maximise their dispensing list, making sure that none of the patients are missing off it, and to try to contain expenditure.

jacki.buist@haymarket.com

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

A question of capacity

Medicolegal advisor, Dr John Holden addresses some dilemmas on consent that may be faced by GPs. Read more

Workplace-based assessment

The WPBA should be seen as a developmental process, says the RCGP's Dr Jane Mamelok. Read more

Professional development - The role of an educational supervisor

Working as an educational supervisor can be stimulating and rewarding, says Dr Alexander Williams. Read more

Show all articles

 

Latest Clinical Articles

Primary hyperparathyroidism

Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more

Clinical Review - Headache in children

Contributed by Dr David Kernick, a GPSI in headache, based in Exeter. Read more

Carpal tunnel syndrome

Section 1: Epidemiology and aetiology Read more

Show all clinical articles

MIMS Product News

Toviaz

New drug - Toviaz

Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more

New drug - Tasigna

Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more

Ciproxin licensed for UTI in children

The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more

Jobs

 

Job of the Week